🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Several experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the service has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or administering at home.

After minutes of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Information and Costs

Inside these communities, messages show black plastic packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant medical dangers”.